Söndag 27 April | 11:25:57 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2025-11-07 08:30 Kvartalsrapport 2025-Q3
2025-08-27 08:30 Kvartalsrapport 2025-Q2
2025-05-20 N/A X-dag ordinarie utdelning SEZI 0.00 SEK
2025-05-19 N/A Årsstämma
2025-04-22 - Kvartalsrapport 2025-Q1
2025-02-17 - Bokslutskommuniké 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-10-23 - Extra Bolagsstämma 2024
2024-08-26 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning SEZI 0.00 SEK
2024-05-16 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-28 - Extra Bolagsstämma 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-17 - X-dag ordinarie utdelning SEZI 0.00 SEK
2023-05-16 - Årsstämma
2023-04-28 - Kvartalsrapport 2023-Q1
2023-02-20 - Bokslutskommuniké 2022
2023-02-16 - Extra Bolagsstämma 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-05-19 - X-dag ordinarie utdelning SEZI 0.00 SEK
2022-05-18 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-12 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-12 - X-dag ordinarie utdelning SEZI 0.00 SEK
2021-05-11 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-03-05 - Extra Bolagsstämma 2021
2021-02-26 - Bokslutskommuniké 2020
2020-11-06 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-07-02 - Extra Bolagsstämma 2020
2020-05-15 - X-dag ordinarie utdelning SEZI 0.00 SEK
2020-05-14 - Årsstämma
2020-05-08 - Kvartalsrapport 2020-Q1
2020-02-14 - Bokslutskommuniké 2019
2019-11-08 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-08-21 - Extra Bolagsstämma 2019
2019-05-09 - X-dag ordinarie utdelning SEZI 0.00 SEK
2019-05-08 - Årsstämma
2019-05-08 - Kvartalsrapport 2019-Q1
2019-02-15 - Bokslutskommuniké 2018
2018-11-08 - Kvartalsrapport 2018-Q3
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-09 - X-dag ordinarie utdelning SEZI 0.00 SEK
2018-05-08 - Årsstämma
2018-05-08 - Kvartalsrapport 2018-Q1
2018-03-05 - Extra Bolagsstämma 2018
2018-02-16 - Bokslutskommuniké 2017
2017-11-28 - Kvartalsrapport 2017-Q3
2017-09-15 - Extra Bolagsstämma 2017
2017-08-31 - Kvartalsrapport 2017-Q2
2017-05-23 - Årsstämma
2017-05-23 - Kvartalsrapport 2017-Q1
2017-02-16 - Bokslutskommuniké 2016
2016-11-22 - Kvartalsrapport 2016-Q3
2016-08-31 - Kvartalsrapport 2016-Q2
2016-05-17 - Extra Bolagsstämma 2016
2016-04-28 - X-dag ordinarie utdelning SEZI 0.00 SEK
2016-04-27 - Årsstämma
2016-04-27 - Kvartalsrapport 2016-Q1
2016-02-18 - Bokslutskommuniké 2015
2015-11-24 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-20 - X-dag ordinarie utdelning SEZI 0.00 SEK
2015-05-19 - Årsstämma
2015-05-19 - Kvartalsrapport 2015-Q1
2015-02-25 - Bokslutskommuniké 2014
2014-11-27 - Kvartalsrapport 2014-Q3
2014-11-21 - Extra Bolagsstämma 2014
2014-08-21 - Kvartalsrapport 2014-Q2
2014-05-15 - X-dag ordinarie utdelning SEZI 0.00 SEK
2014-05-14 - Årsstämma
2014-05-14 - Kvartalsrapport 2014-Q1
2014-02-24 - Bokslutskommuniké 2013
2013-11-27 - Kvartalsrapport 2013-Q3
2013-08-20 - Kvartalsrapport 2013-Q2
2013-05-16 - X-dag ordinarie utdelning SEZI 0.00 SEK
2013-05-15 - Årsstämma
2013-05-15 - Kvartalsrapport 2013-Q1
2013-02-28 - Bokslutskommuniké 2012
2013-01-08 - Extra Bolagsstämma 2013
2012-11-21 - Kvartalsrapport 2012-Q3
2012-08-21 - Kvartalsrapport 2012-Q2
2012-05-24 - X-dag ordinarie utdelning SEZI 0.00 SEK
2012-05-23 - Årsstämma
2012-05-23 - Kvartalsrapport 2012-Q1
2012-02-22 - Bokslutskommuniké 2011
2011-11-23 - Kvartalsrapport 2011-Q3
2011-08-23 - Kvartalsrapport 2011-Q2
2011-05-27 - X-dag ordinarie utdelning SEZI 0.00 SEK
2011-05-26 - Årsstämma
2011-05-26 - Kvartalsrapport 2011-Q1
2011-02-16 - Bokslutskommuniké 2010
2010-11-24 - Kvartalsrapport 2010-Q3
2010-05-28 - X-dag ordinarie utdelning SEZI 0.00 SEK
2010-05-27 - Kvartalsrapport 2010-Q1
2009-11-25 - Kvartalsrapport 2009-Q3

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Senzime är verksamt inom medicinteknikbranschen och fokuserar på utveckling och tillverkning av system för övervakning och diagnostik inom sjukvården. I portföljen ingår system som används för att automatisera och mäta ämnena glukos och laktat i blod och vävnader. Bolagets produkter riktar sig till sjukvårdsinstitutioner och läkare. Verksamheten är global. Senzime grundades 1999 och har sitt huvudkontor i Uppsala.
2023-03-10 15:15:00

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE CONTRAVENING TO ANY APPLICABLE RULES OR REQUIRE REGISTRATION OR OTHER ACTIONS.

The final result of the rights issue (the ”Rights Issue”) in Senzime AB (publ) (“Senzime” or the “Company”) shows that the Rights Issue was subscribed to approximately 67.8 per cent, corresponding to 9,481,604 shares. In addition, 3,201,071 shares, corresponding to approximately 22.9 per cent of the offered shares, have been allocated to underwriters. Through the Rights Issue, Senzime will receive proceeds of approximately SEK 91.9 million before deduction of transaction costs.

Through the Rights Issue, Senzime’s share capital increases by SEK 1,585,334.375 from SEK 8,735,498.125 to SEK 10,320,832.500 by issue of 12,682,675 new shares, which means that the total number of shares increases from 69,883,985 shares to 82,566,660 shares.

Allocation of shares subscribed for without subscription rights has been made in accordance with the principles in the prospectus published by Senzime on 16 February 2023. As confirmation of allocation of shares subscribed for without subscription rights, a contract note will be sent on or about 10 March 2023. Subscribed and allocated shares must be paid for in cash in accordance with the instructions in the contract note. Nominee-registered shareholders will receive notice of allocation in accordance with the procedures of the nominee. Only those who are allocated shares will be notified.

The final day for trading in paid subscribed shares (SWE: betald tecknad aktie) is 20 March 2023. The new shares subscribed for with subscription rights are expected to be registered with the Swedish Companies Registration Office (SWE: Bolagsverket) around 13–14 March 2023. The new shares are expected to start trading on Nasdaq Stockholm from 24 March 2023.

Advisers

In connection with the Rights Issue, the Company has retained Danske Bank A/S, Danmark, Sverige Filial as Sole Global Coordinator and Bookrunner and Advokatfirman Lindahl KB as legal adviser to the Company.

This press release is an English translation of the Swedish original. In the event of any discrepancies, the Swedish version shall govern.

Important information

The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to restrictions. The recipients of this press release in jurisdictions where this press release has been published or distributed shall inform themselves of and follow such restrictions. The recipient of this press release is responsible for using this press release, and the information contained herein, in accordance with applicable rules in each jurisdiction.

This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in the Company in any jurisdiction, neither from the Company nor from someone else. No action has been taken, and no action will be taken, to allow a public offering in any jurisdiction other than Sweden. An invitation to eligible persons to subscribe for shares in the Company has only been made through the prospectus that the Company published 16 February 2023.

The information in this press release may not be announced, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, within or into the United States of America, including its territories and possessions, any state of the United States and the District of Columbia (the “United States”), Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or South Korea or in any other jurisdiction where such announcement, publication or distribution of the information would not comply with applicable laws and regulations or where such actions are subject to legal restrictions or would require additional registration or other measures than what is required under Swedish law. Actions taken in violation of this instruction may constitute a crime against applicable securities laws and regulations.

This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

Within the European Economic Area ("EEA"), no public offering is intended to be made in any member state other than Sweden. In other member states of the EEA where the Prospectus Regulation applies, an offer of securities may only be made in accordance with exemptions in the Prospectus Regulation and any implementing measures. In the United Kingdom, an offering of securities may only be made to qualified investors in accordance with exemptions in the Prospectus Regulation and applicable law in the United Kingdom. Persons in any member state of the EEA other than Sweden or in the United Kingdom who are not qualified investors under applicable law should not take any action based on this press release, nor should they rely on it.

Forward-looking statements

This press release may contain forward-looking information that reflects the Company's current views on future events and financial and operational development. Words such as "intend", "estimate", "expect", "may", "plan", "estimate" and other expressions that imply indications or predictions of future developments or trends, and which are not based on historical facts, constitute forward-looking information. By their nature, forward-looking statements involve both known and unknown risks and uncertainties because they depend on future events and circumstances. Forward-looking information is not a guarantee of future performance or development and actual results may differ materially from those expressed in forward-looking statements. The information, opinions and forward-looking statements expressed or implied herein speak only as of the date of this press release and are subject to change. Neither the Company nor anyone else undertakes to review, update, confirm or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this press release, unless it is required by law or Nasdaq Stockholm's rule book for issuers.